Patents Assigned to AlzeCure Pharma AB
  • 4-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptors
    Patent number: 11840524
    Abstract: There is provided a compound of formula (I), wherein R1, R2, R3, Q1, Q2, Q3, X, A and n are as defined herein, which compounds are useful in the treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: December 12, 2023
    Assignee: ALZECURE PHARMA AB
    Inventors: Gunnar Nordvall, Pontus Forsell
  • Triazine derivatives for treating diseases relating to neurotrophins
    Patent number: 11352332
    Abstract: There is provided herein a compound of formula (I) wherein R1, R2, n, X, Q, L, m, R3 and p are as defined herein, which compounds are useful in the treatment of treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: June 7, 2022
    Assignee: AlzeCure Pharma AB
    Inventor: Gunnar Nordvall
  • TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS
    Publication number: 20200399230
    Abstract: There is provided herein a compound of formula (I) wherein R1, R2, n, X, Q, L, m, R3 and p are as defined herein, which compounds are useful in the treatment of treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 24, 2020
    Applicant: AlzeCure Pharma AB
    Inventors: Gunnar Nordvall, Pontus Forsell